Hit enter to search or ESC to close
Sigrid Therapeutics
  • About Us
    • Our Story
    • The Team
    • Board of Directors
    • Advisory Board
  • R&D
    • SiPore®
    • Clinical Trials
    • Prediabetes
    • Pipeline
    • Posters & Publications
  • Resources
    • Logo
  • News
    • Media
    • Photos
  • Contact Us
  • Consumer Pre-launch Program
Sigrid Therapeutics
News

Major Swedish study provides additional proof of concept for Sigrid’s medical device SiPore15 for preventing diabetes and treating obesity

Tiny mesoporous silica particles block food enzymes reducing metabolic risk factors and blood sugar levels…
Liu Ming
Liu MingMay 4, 2020
Hiring

Summer internship position at Sigrid Therapeutics

ARE YOU OUR NEXT SUMMER INTERN? Summer internship position at Sigrid Therapeutics Sigrid Therapeutics (Sigrid)…
Liu Ming
Liu MingApril 23, 2020
News

The Stockholm Material Hub, of which Sigrid Therapeutics is a long-term collaborator of, receives €0.5 M boost from European Regional Development Fund

Sigrid Therapeutics today announced that the Stockholm Material Hub, a long-term collaboration partner of the…
Liu Ming
Liu MingMarch 25, 2020
News

Stockholm Material Hub, vilken Sigrid Therapeutics är en nyckelpartner till, erhåller €0,5 miljoner i bidrag från Europeiska Regionala Utvecklingsfonden

Sigrid Therapeutics meddelade idag att Stockholm Material Hub, företagets samarbetspartner sedan länge, har säkrat €0,5 miljoner…
Liu Ming
Liu MingMarch 25, 2020
News

Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut

LABIOTECH.eu
Sana
SanaFebruary 7, 2020
News

Kan deras nanopulver motverka diabetes?

NyTeknik
Sana
SanaJanuary 21, 2020
News

New study in mice published in Nanomedicine shows Sigrid’s medical device SiPore15 prevents weight gain

New study in mice published in Nanomedicine shows Sigrid’s medical device SiPore15 prevents weight gain…
Liu Ming
Liu MingJanuary 15, 2020
News

Sigrid Therapeutics Takes Another Step Towards a Treatment for Prevention of Type 2 diabetes

Sigrid Therapeutics Reports Significant Blood Sugar Reduction with Excellent Safety Profile in STAR Trial with…
Liu Ming
Liu MingSeptember 26, 2019
News

Stockholm-based technology startup Sigrid Therapeutics, developing SiPore15TM – a breakthrough device to lower blood sugar levels, closes oversubscribed round of $1.6M, bringing total pre-launch funding to $9M

Stockholm, Sweden, September 5, 2019 – Sigrid Therapeutics AB, an innovative technology company developing a…
Liu Ming
Liu MingSeptember 5, 2019
News

Sigrid Therapeutics announces that all patients have completed treatment with SiPore15 in the STAR Trial

First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors.…
Morgan
MorganJuly 16, 2019
« Previous Entries
Next Entries »

© 2022 Sigrid Therapeutics.

    • About Us
      • Our Story
      • The Team
      • Board of Directors
      • Advisory Board
    • R&D
      • SiPore®
      • Clinical Trials
      • Prediabetes
      • Pipeline
      • Posters & Publications
    • Resources
      • Logo
    • News
      • Media
      • Photos
    • Contact Us
    • Consumer Pre-launch Program